ID   Karpas-1272
AC   CVCL_9554
SY   Karpas 1272; Karpas1272
DR   cancercelllines; CVCL_9554
DR   Cosmic; 720772
DR   Wikidata; Q54899483
RX   PubMed=10936422;
RX   PubMed=11157491;
RX   PubMed=15621787;
CC   Sequence variation: Mutation; HGNC; 6407; KRAS; Simple; p.Gln61His (c.183A>C); ClinVar=VCV000177881; Zygosity=Unspecified (PubMed=11157491).
CC   Derived from site: In situ; Peripheral blood; UBERON=UBERON_0000178.
DI   NCIt; C3242; Plasma cell myeloma
DI   ORDO; Orphanet_29073; Multiple myeloma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Male
AG   36Y
CA   Cancer cell line
DT   Created: 06-06-12; Last updated: 05-10-23; Version: 14
//
RX   PubMed=10936422; DOI=10.1016/S0145-2126(99)00195-2;
RA   Drexler H.G., Matsuo Y.;
RT   "Malignant hematopoietic cell lines: in vitro models for the study of
RT   multiple myeloma and plasma cell leukemia.";
RL   Leuk. Res. 24:681-703(2000).
//
RX   PubMed=11157491; DOI=10.1182/blood.V97.3.729;
RA   Chesi M., Brents L.A., Ely S.A., Bais C., Robbiani D.F., Mesri E.A.,
RA   Kuehl W.M., Bergsagel P.L.;
RT   "Activated fibroblast growth factor receptor 3 is an oncogene that
RT   contributes to tumor progression in multiple myeloma.";
RL   Blood 97:729-736(2001).
//
RX   PubMed=15621787; DOI=10.1080/10428190400002244;
RA   Karpas A., Harder L., Czepulkowski B.H., Bloxham D., Saward R.,
RA   Dremucheva A., Siebert R.;
RT   "Studies of four new human myeloma cell lines.";
RL   Leuk. Lymphoma 46:101-112(2005).
//